These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36765581)

  • 1. c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy.
    Chen Y; León-Letelier RA; Abdel Sater AH; Vykoukal J; Dennison JB; Hanash S; Fahrmann JF
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine synthesis as a target of
    Bachmann AS; Geerts D
    J Biol Chem; 2018 Nov; 293(48):18757-18769. PubMed ID: 30404920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer.
    Fahrmann JF; Irajizad E; Kobayashi M; Vykoukal J; Dennison JB; Murage E; Wu R; Long JP; Do KA; Celestino J; Lu KH; Lu Z; Bast RC; Hanash S
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.
    Evageliou NF; Hogarty MD
    Clin Cancer Res; 2009 Oct; 15(19):5956-61. PubMed ID: 19789308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.
    Rounbehler RJ; Li W; Hall MA; Yang C; Fallahi M; Cleveland JL
    Cancer Res; 2009 Jan; 69(2):547-53. PubMed ID: 19147568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
    Hogarty MD; Norris MD; Davis K; Liu X; Evageliou NF; Hayes CS; Pawel B; Guo R; Zhao H; Sekyere E; Keating J; Thomas W; Cheng NC; Murray J; Smith J; Sutton R; Venn N; London WB; Buxton A; Gilmour SK; Marshall GM; Haber M
    Cancer Res; 2008 Dec; 68(23):9735-45. PubMed ID: 19047152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
    Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
    Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
    Ruiz-Pérez MV; Medina MÁ; Urdiales JL; Keinänen TA; Sánchez-Jiménez F
    J Biol Chem; 2015 Mar; 290(10):6106-19. PubMed ID: 25593318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyramide Signal-Amplified Immunofluorescence of MYCN and MYC in Human Tissue Specimens and Cell Line Cultures.
    Schafer JM; Pietenpol JA
    Bio Protoc; 2020 Jul; 10(13):e3677. PubMed ID: 33659347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
    Tateishi K; Iafrate AJ; Ho Q; Curry WT; Batchelor TT; Flaherty KT; Onozato ML; Lelic N; Sundaram S; Cahill DP; Chi AS; Wakimoto H
    Clin Cancer Res; 2016 Sep; 22(17):4452-65. PubMed ID: 27076630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection.
    Snezhkina AV; Krasnov GS; Lipatova AV; Sadritdinova AF; Kardymon OL; Fedorova MS; Melnikova NV; Stepanov OA; Zaretsky AR; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
    Oxid Med Cell Longev; 2016; 2016():2353560. PubMed ID: 27433286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.
    Gamble LD; Hogarty MD; Liu X; Ziegler DS; Marshall G; Norris MD; Haber M
    Front Oncol; 2012; 2():162. PubMed ID: 23181218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers.
    Chabanon RM; Postel-Vinay S
    Cancer Res; 2022 Mar; 82(6):969-971. PubMed ID: 35288735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers.
    Tran HN; Singh HP; Guo W; Cambier L; Riggan L; Shackleford GM; Thornton ME; Grubbs BH; Erdreich-Epstein A; Qi DL; Cobrinik D
    Front Oncol; 2020; 10():563156. PubMed ID: 33425720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC, MYCL, and MYCN as therapeutic targets in lung cancer.
    Massó-Vallés D; Beaulieu ME; Soucek L
    Expert Opin Ther Targets; 2020 Feb; 24(2):101-114. PubMed ID: 32003251
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer Progression.
    Gao J; Jung M; Mayoh C; Venkat P; Hannan KM; Fletcher JI; Kamili A; Gifford AJ; Kusnadi EP; Pearson RB; Hannan RD; Haber M; Norris MD; Somers K; Henderson MJ
    Cancer Res; 2020 Sep; 80(17):3706-3718. PubMed ID: 32651259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the MYCN protein with small molecule c-MYC inhibitors.
    Müller I; Larsson K; Frenzel A; Oliynyk G; Zirath H; Prochownik EV; Westwood NJ; Henriksson MA
    PLoS One; 2014; 9(5):e97285. PubMed ID: 24859015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting
    Liu Z; Chen SS; Clarke S; Veschi V; Thiele CJ
    Front Oncol; 2020; 10():623679. PubMed ID: 33628735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers.
    Hasegawa-Minato J; Toyoshima M; Ishibashi M; Zhang X; Shigeta S; Grandori C; Kitatani K; Yaegashi N
    Oncotarget; 2018 Jan; 9(3):3483-3496. PubMed ID: 29423060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-MYC Inhibited Ferroptosis and Promoted Immune Evasion in Ovarian Cancer Cells through NCOA4 Mediated Ferritin Autophagy.
    Jin Y; Qiu J; Lu X; Li G
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.